| Scott Bin-ti Hu, MD | |
|
15503 Ventura Blvd Ste 170, Encino, CA 91436-3145 | |
| (818) 461-8148 | |
| Not Available |
| Full Name | Scott Bin-ti Hu |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 18 Years |
| Location | 15503 Ventura Blvd Ste 170, Encino, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376794420 | NPI | - | NPPES |
| 0A1015830 | Medicaid | CA | |
| A101583 | Other | CA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | A101583 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Hills Hospital & Medical Center | West hills, CA | Hospital |
| Ronald Reagan Ucla Medical Center | Los angeles, CA | Hospital |
| Henry Mayo Newhall Hospital | Valencia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Regents Of The University Of California | 1355248584 | 1177 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
The University of Manchester study found that wearers who failed to remove their lenses before bedtime had an increased risk of developing keratitis than those who routinely took out their lenses before going to sleep.
ThermoGenesis Corp., a leading supplier of innovative products and services that process and store human cell concentrates, said today it has entered into a five year collaboration with Arthrex, Inc., under which Arthrex will market ThermoGenesis' Res-Q 60 (Res-Q) System technology for use in the preparation of autologous Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC).
ERYtech Pharma announces that FDA has granted an Orphan Drug Designation (ODD) for GRASPA®, the company's lead product in Acute Lymphoblastic Leukaemia.
The Washington Global Health Alliance, a group representing 26 life-sciences businesses, institutions and governmental organizations, has completed an internal coordination study demonstrating the significant influence of its primary partners in the mission of global health.
› Verified 6 days ago
| Entity Name | The Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235107566 PECOS PAC ID: 1355248584 Enrollment ID: O20031223000439 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
The University of Manchester study found that wearers who failed to remove their lenses before bedtime had an increased risk of developing keratitis than those who routinely took out their lenses before going to sleep.
ThermoGenesis Corp., a leading supplier of innovative products and services that process and store human cell concentrates, said today it has entered into a five year collaboration with Arthrex, Inc., under which Arthrex will market ThermoGenesis' Res-Q 60 (Res-Q) System technology for use in the preparation of autologous Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC).
ERYtech Pharma announces that FDA has granted an Orphan Drug Designation (ODD) for GRASPA®, the company's lead product in Acute Lymphoblastic Leukaemia.
The Washington Global Health Alliance, a group representing 26 life-sciences businesses, institutions and governmental organizations, has completed an internal coordination study demonstrating the significant influence of its primary partners in the mission of global health.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Bin-ti Hu, MD 5767 W Century Blvd Ste 400, Los Angeles, CA 90045-5631 Ph: (310) 301-5200 | Scott Bin-ti Hu, MD 15503 Ventura Blvd Ste 170, Encino, CA 91436-3145 Ph: (818) 461-8148 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
The University of Manchester study found that wearers who failed to remove their lenses before bedtime had an increased risk of developing keratitis than those who routinely took out their lenses before going to sleep.
ThermoGenesis Corp., a leading supplier of innovative products and services that process and store human cell concentrates, said today it has entered into a five year collaboration with Arthrex, Inc., under which Arthrex will market ThermoGenesis' Res-Q 60 (Res-Q) System technology for use in the preparation of autologous Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC).
ERYtech Pharma announces that FDA has granted an Orphan Drug Designation (ODD) for GRASPA®, the company's lead product in Acute Lymphoblastic Leukaemia.
The Washington Global Health Alliance, a group representing 26 life-sciences businesses, institutions and governmental organizations, has completed an internal coordination study demonstrating the significant influence of its primary partners in the mission of global health.
› Verified 6 days ago
Zoraida I Suarez, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5363 Balboa Blvd, Ste 433, Encino, CA 91316 Phone: 818-788-8838 Fax: 818-788-0851 | |
Dr. Arnold Zorel Paritzky, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 16133 Ventura Blvd, Suite 1180, Encino, CA 91436 Phone: 818-990-5756 | |
Dr. Darius Gharib, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 16133 Ventura Blvd, 350, Encino, CA 91436 Phone: 818-501-5201 Fax: 818-530-5322 | |
Keyvan Shirazi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 16952 Ventura Blvd, Encino, CA 91316 Phone: 818-789-3964 Fax: 818-789-3967 | |
Dr. Kamran Christopher Rabbani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5363 Balboa Blvd, 542, Encino, CA 91316 Phone: 818-788-9200 Fax: 818-788-9621 | |
Dr. Esfandiar Esfandiarifard, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 16661 Ventura Blvd Ste 515, Encino, CA 91436 Phone: 818-990-4030 Fax: 818-990-4031 | |
Allen Tabibian, Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 16500 Ventura Blvd, Suite # 418, Encino, CA 91436 Phone: 818-905-1240 Fax: 818-905-1238 |